Drugs Made In America Acquisition Corp. DMAAU
11.15 USD +0.14 (+1.27%)
At closeNov 3, 2026, 4:00 PM EST
10.56 -0.59 -5.29%
After hours · Nov 3, 4:00 PM ET
11.15 Day range 11.15
10.30 52-week range 12.50
- YTD
- +6.29%
- 1 year
- +5.39%
Financial health
Altman Z-Score
23.14 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 5
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 54.6×
FY 2024 5y median -61.6× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 0.9×
FY 2024 5y median -174932× FY 2025
P/FCF -404×
FY 2024 5y median -144892× FY 2025
EV/EBITDA -77.4×
FY 2024 5y median 50.4× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -0.2%
FY 2024 5y median -0.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 2.6%
FY 2024 5y median 99.4% FY 2025
ROIC -1.2%
FY 2024 5y median -5.0% FY 2025
ROA 2.5%
FY 2024 5y median -42.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -587794.2%
FY 2024 FY 2025
EPS (diluted) 439.3%
FY 2024 FY 2025
Free Cash Flow -182675.3%
FY 2024 FY 2025
Financial Health
Current Ratio 0.0×
FY 2024 5y median 3.2× FY 2025
Quick Ratio 0.0×
FY 2024 5y median 3.2× FY 2025
Debt / Equity 0.0×
FY 2024 5y median -1.4× FY 2025
Net Debt / EBITDA 0.0×
FY 2024 5y median 0.0× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31